Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oncternal Therapeutics, Inc.

0.5266
+0.0000
Volume:- -
Turnover:- -
Market Cap:1.56M
PE:-0.05
High:0.5266
Open:0.5266
Low:0.5266
Close:0.5266
Loading ...
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 27, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 17, 2025

Voluntary Delisting

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Nov 25, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report